Literature DB >> 9241463

Strategies for diagnosing and managing medication-induced headache.

J G Edmeads1, M J Gawel, J Vickers.   

Abstract

PROBLEM ADDRESSED: Headache is a common clinical disorder. Nearly 50% of patients with headaches use prescription medications, and 90% regularly use nonprescription drugs. Medication-induced headaches (MIH) are chronic daily headaches caused by overuse of medicine.
OBJECTIVES: To summarize the diagnostic criteria for MIH, to determine the investigations necessary to confirm the diagnosis and exclude other possible diagnoses, and to establish recommendations for managing MIH. MAIN
FINDINGS: Diagnosis of MIH is based on patient's history and the clinical characteristics of the headache. Treatment includes patient education and support, withdrawal of offending medications, relief of withdrawal symptoms, and specific treatment of residual headache. When migraine and other causes of headache are adequately addressed, patients will not seek additional pain relief.
CONCLUSION: Medication-induced headache is preventable. The key to prevention is appropriate drug therapy to relieve the primary headache. All patients with MIH can be treated and most cured.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9241463      PMCID: PMC2255116     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  37 in total

1.  Long-term results of migraine prophylaxis with flunarizine and beta-blockers.

Authors:  C Wöber; C Wöber-Bingöl; G Koch; P Wessely
Journal:  Cephalalgia       Date:  1991-12       Impact factor: 6.292

2.  Oral sumatriptan in acute migraine.

Authors:  P J Goadsby; A S Zagami; G A Donnan; G Symington; M Anthony; P F Bladin; J W Lance
Journal:  Lancet       Date:  1991-09-28       Impact factor: 79.321

3.  Treatment of acute migraine attack: ibuprofen and placebo compared.

Authors:  H Havanka-Kanniainen
Journal:  Headache       Date:  1989-09       Impact factor: 5.887

4.  A double-blind study of ibuprofen versus placebo in the treatment of acute migraine attacks.

Authors:  R Kloster; K Nestvold; S T Vilming
Journal:  Cephalalgia       Date:  1992-06       Impact factor: 6.292

5.  Drug induced refractory headache--clinical features and management.

Authors:  N T Mathew; R Kurman; F Perez
Journal:  Headache       Date:  1990-10       Impact factor: 5.887

6.  Naproxen sodium versus ergotamine tartrate in the treatment of acute migraine attacks.

Authors:  T A Treves; M Streiffler; A D Korczyn
Journal:  Headache       Date:  1992-06       Impact factor: 5.887

7.  Treatment of acute migraine with subcutaneous sumatriptan.

Authors:  R K Cady; J K Wendt; J R Kirchner; J D Sargent; J F Rothrock; H Skaggs
Journal:  JAMA       Date:  1991-06-05       Impact factor: 56.272

Review 8.  Therapeutic advances in migraine.

Authors:  G D Solomon
Journal:  J Clin Pharmacol       Date:  1993-03       Impact factor: 3.126

9.  Chronic daily headache: long-term prognosis following inpatient treatment with repetitive IV DHE.

Authors:  S D Silberstein; J R Silberstein
Journal:  Headache       Date:  1992-10       Impact factor: 5.887

10.  Transformed migraine.

Authors:  N T Mathew
Journal:  Cephalalgia       Date:  1993-04       Impact factor: 6.292

View more
  2 in total

1.  Analysis and quantification of self-medication patterns of customers in community pharmacies in southern Chile.

Authors:  Katherine Fuentes Albarrán; Lorenzo Villa Zapata
Journal:  Pharm World Sci       Date:  2008-08-20

Review 2.  Medication overuse headache: awareness, detection and treatment.

Authors:  Alan M Rapoport
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.